Coverart for item
The Resource Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies : workshop summary, Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies, (electronic resource)

Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies : workshop summary, Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies, (electronic resource)

Label
Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies : workshop summary
Title
Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies
Title remainder
workshop summary
Statement of responsibility
Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies
Creator
Contributor
Subject
Genre
Language
eng
Summary
"One of the challenges in treating cancer is the disease's complexity and variation among patients. Cancer manifests differently in each patient, so treatments that are effective in one patient may not be effective in another. As cancer care becomes more personalized, subpopulations of individuals will be given preventive or therapeutic interventions based on their susceptibility to a particular disease or their predicted response to a specific treatment. However, before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of technological, regulatory, and reimbursement issues. To explore these policy challenges, the National Cancer Policy Forum held the workshop Policy Issues in the Development of Personalized Medicine in Oncology in June 2009. Experts provided presentations on the current state of personalized medicine technology, as well as issues in the validation of, regulation of, and reimbursement for the predictive tests that underpin personalized medicine. Participants discussed the obstacles and possible solutions to further developing and using personalized medicine technologies. This document summarizes the workshop"--
Assigning source
Publisher's description
Cataloging source
NRZ
Dewey number
362.19699/4
LC call number
RC270.8
LC item number
.P65 2014
http://bibfra.me/vocab/lite/meetingDate
2014
http://bibfra.me/vocab/lite/meetingName
Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer (Workshop)
http://library.link/vocab/relatedWorkOrContributorName
  • Patlak, Margie
  • Nass, Sharyl J
  • Phillips, Jonathan
  • National Cancer Policy Forum (U.S.)
  • Institute of Medicine (U.S.)
http://library.link/vocab/subjectName
  • Cancer
  • Cancer
  • Biochemical markers
  • Biomarkers
  • Neoplasms
  • Health Policy
  • Molecular Targeted Therapy
  • United States
  • United States
  • Biochemical markers
  • Cancer
  • Cancer
  • United States
Label
Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies : workshop summary, Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies, (electronic resource)
Instantiates
Publication
Bibliography note
Includes bibliographical references (p. 76-80)
Contents
Molecular biology revolution in cancer diagnosis and treatment -- Challenges in biomarker test development -- Regulatory oversight challenges -- Clinical implementation challenges -- Reimbursement challenges -- Gathering the evidence : innovative clinical trials -- Gathering the evidence : coverage decisions -- Gathering the evidence : databases and registries -- Education and clinical decision support needs
Control code
OCM1bookssj0001591991
Dimensions
unknown
Isbn
9780309368575
Lccn
2015458702
Specific material designation
remote
System control number
(WaSeSS)bookssj0001591991
Label
Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies : workshop summary, Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies, (electronic resource)
Publication
Bibliography note
Includes bibliographical references (p. 76-80)
Contents
Molecular biology revolution in cancer diagnosis and treatment -- Challenges in biomarker test development -- Regulatory oversight challenges -- Clinical implementation challenges -- Reimbursement challenges -- Gathering the evidence : innovative clinical trials -- Gathering the evidence : coverage decisions -- Gathering the evidence : databases and registries -- Education and clinical decision support needs
Control code
OCM1bookssj0001591991
Dimensions
unknown
Isbn
9780309368575
Lccn
2015458702
Specific material designation
remote
System control number
(WaSeSS)bookssj0001591991

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...